C. Wolfgang

发表

Activating Transcription Factor 3, a Stress-inducible Gene, Suppresses Ras-stimulated Tumorigenesis*

Tsonwin Hai, D. Lu, C. Wolfgang, 2006, Journal of Biological Chemistry.

Tsonwin Hai, C. Wolfgang, D. K. Marsee, 1999, Gene expression.

The T Cell Receptor γ Chain Alternate Reading Frame Protein (TARP), a Prostate-specific Protein Localized in Mitochondria*

Ira Pastan, I. Pastan, C. Wolfgang, 2004, Journal of Biological Chemistry.

Association of the NPAS3 gene and five other loci with response to the antipsychotic iloperidone identified in a whole genome association study

M. Polymeropoulos, S. Volpi, L. Licamele, 2009, Molecular Psychiatry.

PAGE4 is a cytoplasmic protein that is expressed in normal prostate and in prostate cancers.

I. Pastan, M. Willingham, P. Duray, 2002, Molecular cancer therapeutics.

PRAC: A novel small nuclear protein that is specifically expressed in human prostate and colon

I. Pastan, P. Duray, Byungkook Lee, 2001, The Prostate.

Effect of a ciliary neurotrophic factor polymorphism on schizophrenia symptom improvement in an iloperidone clinical trial.

M. Polymeropoulos, S. Volpi, C. Wolfgang, 2008, Pharmacogenomics.

A Randomized Trial of Iloperidone for Prevention of Relapse in Schizophrenia: The REPRIEVE Study

P. Weiden, C. Wolfgang, J. M. Ryan, 2016, CNS Drugs.

Whole genome association study identifies polymorphisms associated with QT prolongation during iloperidone treatment of schizophrenia

M. Polymeropoulos, S. Volpi, L. Licamele, 2009, Molecular Psychiatry.

Four-Week, Double-Blind, Placebo- and Ziprasidone-Controlled Trial of Iloperidone in Patients With Acute Exacerbations of Schizophrenia

P. Weiden, C. Wolfgang, A. Kalali, 2008, Journal of clinical psychopharmacology.

Efficacy of Iloperidone in the Treatment of Schizophrenia: Initial Phase 3 Studies

S. Potkin, C. Wolfgang, R. Litman, 2008, Journal of clinical psychopharmacology.

Long-Term Efficacy and Safety of Iloperidone: Results From 3 Clinical Trials for the Treatment of Schizophrenia

J. Lauriello, E. Laska, J. Kane, 2008, Journal of clinical psychopharmacology.

Safety Profile of Iloperidone: A Pooled Analysis of 6-Week Acute-Phase Pivotal Trials

M. Polymeropoulos, P. Weiden, C. Wolfgang, 2008, Journal of clinical psychopharmacology.

gadd153/Chop10, a potential target gene of the transcriptional repressor ATF3

Tsonwin Hai, N. Holbrook, J. Martindale, 1997, Molecular and cellular biology.

Tissue-specific Pattern of Stress Kinase Activation in Ischemic/Reperfused Heart and Kidney*

Tsonwin Hai, J. Whelan, C. Wolfgang, 1997, The Journal of Biological Chemistry.

Analysis of ATF3, a transcription factor induced by physiological stresses and modulated by gadd153/Chop10

C. Wolfgang, B. P. Chen, T. Hai, 1996, Molecular and cellular biology.

ATF3 Gene

B. Chen, Tsonwin Hai, C. Wolfgang, 1996, The Journal of Biological Chemistry.

NGEP, a gene encoding a membrane protein detected only in prostate cancer and normal prostate.

Byungkook Lee, Yoonsoo Hahn, Ira Pastan, 2004, Proceedings of the National Academy of Sciences of the United States of America.

Transcriptional Autorepression of the Stress-inducible GeneATF3 *

Tsonwin Hai, C. Wolfgang, A. E. Allen, 2000, The Journal of Biological Chemistry.

TARP: a nuclear protein expressed in prostate and breast cancer cells derived from an alternate reading frame of the T cell receptor gamma chain locus.

James J. Vincent, I. Pastan, Byungkook Lee, 2000, Proceedings of the National Academy of Sciences of the United States of America.

T-cell receptor gamma chain alternate reading frame protein (TARP) expression in prostate cancer cells leads to an increased growth rate and induction of caveolins and amphiregulin.

I. Pastan, M. Essand, C. Wolfgang, 2001, Cancer research.

Abstract PS12-04: Rintodestrant (G1T48), an oral selective estrogen receptor degrader in ER+/HER2- locally advanced or metastatic breast cancer: Updated phase 1 results and dose selection

P. Neven, A. Jager, M. Cristofanilli, 2021 .

Translating the Genome into individualized therapeutics

M. Polymeropoulos, C. Wolfgang, C. Lavedan, 2004 .

A Pharmacokinetic (PK)-Pharmacodynamic (PD) Relationship Exists for Efficacy of Iloperidone, a Novel Investigational Atypical Antipsychotic Agent

C. Wolfgang, P. Baroldi, D. Fisher, 2007 .

Four-Week, Double-Blind, Placebo- and Ziprasidone-Controlled Trial of Iloperidone in Patients With Acute Exacerbations of Schizophrenia

P. Weiden, C. Wolfgang, A. Kalali, 2008, Journal of clinical psychopharmacology.

Iloperidone Is Well Tolerated by Subjects With Renal or Hepatic Impairment in Single-Dose Clinical Pharmacokinetic Studies

C. Wolfgang, 2007 .

Genotyping Facilitates Individualized Prediction of Pharmacokinetic Exposure of Iloperidone in Extensive and Poor CYP2D6 Metabolizers

C. Wolfgang, 2007 .

334P Lerociclib (G1T38), a continuously dosed oral CDK4/6 inhibitor, with fulvestrant in HR+/HER2- advanced breast cancer patients: Updated phase II results and dose selection

A. Wardley, R. Roylance, C. Wolfgang, 2020 .